Page last updated: 2024-09-03

tyrosyl-glycyl-glycine and Breast Neoplasms

tyrosyl-glycyl-glycine has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bojková, B; Demečková, V; Gancarčiková, S; Hrčková, G; Kassayová, M; Mudroňová, D; Solár, P1
Armstrong, K; Banerjee, N; Ghilchick, M; Parish, DC; Reed, MJ1

Other Studies

2 other study(ies) available for tyrosyl-glycyl-glycine and Breast Neoplasms

ArticleYear
Immodin and its immune system supportive role in paclitaxel therapy of 4T1 mouse breast cancer.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 89

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Female; Immune System; Leukocytes; Lymphocytes; Lymphokines; Mice; Mice, Inbred BALB C; Monocytes; Paclitaxel

2017
Neutral endopeptidase activity in breast cysts.
    Biochemical Society transactions, 1996, Volume: 24, Issue:3

    Topics: Breast Neoplasms; Enkephalin, Methionine; Female; Fibrocystic Breast Disease; Humans; Leucyl Aminopeptidase; Neprilysin; Oligopeptides; Spectrometry, Fluorescence; Substrate Specificity

1996